The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121177428 12117742 8 F 20091218 20160708 20160226 20160719 EXP CA-ROCHE-1716762 ROCHE 26.05 YR F Y 130.80000 KG 20160719 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121177428 12117742 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW S0058A,S0065E,S0066B 103976 375 MG SOLUTION FOR INJECTION QOW
121177428 12117742 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 375 MG SOLUTION FOR INJECTION QOW
121177428 12117742 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 375 MG SOLUTION FOR INJECTION QOW
121177428 12117742 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 375 MG SOLUTION FOR INJECTION QOW
121177428 12117742 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 SOLUTION FOR INJECTION
121177428 12117742 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 SOLUTION FOR INJECTION
121177428 12117742 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 SOLUTION FOR INJECTION
121177428 12117742 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 SOLUTION FOR INJECTION
121177428 12117742 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 SOLUTION FOR INJECTION
121177428 12117742 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 SOLUTION FOR INJECTION
121177428 12117742 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK S0058A,S0065E,S0066B 103976 SOLUTION FOR INJECTION
121177428 12117742 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0058A,S0065E,S0066B 103976 375 MG SOLUTION FOR INJECTION QOW
121177428 12117742 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous S0058A,S0065E,S0066B 103976 375 MG SOLUTION FOR INJECTION QOW
121177428 12117742 14 SS BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Unknown U 0
121177428 12117742 15 C VENTOLINE ALBUTEROL 1 Unknown U 0
121177428 12117742 16 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown UNK, BID U 0 BID
121177428 12117742 17 C FLOVENT FLUTICASONE PROPIONATE 1 Unknown 500 OT, BID 0 BID
121177428 12117742 18 C PREDNISONE. PREDNISONE 1 Unknown 7.5 MG, QD U 0 7.5 MG QD
121177428 12117742 19 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown U 0 TABLET
121177428 12117742 20 C LANTUS INSULIN GLARGINE 1 Unknown U 0
121177428 12117742 21 C ADVIL IBUPROFEN 1 Unknown PRN U 0
121177428 12117742 22 C INSULIN INSULIN NOS 1 Unknown UNK U 0
121177428 12117742 23 C REPAGLINIDE. REPAGLINIDE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121177428 12117742 1 Asthma
121177428 12117742 14 Pruritus
121177428 12117742 15 Product used for unknown indication
121177428 12117742 16 Product used for unknown indication
121177428 12117742 17 Product used for unknown indication
121177428 12117742 18 Product used for unknown indication
121177428 12117742 19 Product used for unknown indication
121177428 12117742 20 Product used for unknown indication
121177428 12117742 21 Product used for unknown indication
121177428 12117742 22 Product used for unknown indication
121177428 12117742 23 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
121177428 12117742 OT
121177428 12117742 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121177428 12117742 Angina pectoris
121177428 12117742 Arteriosclerosis
121177428 12117742 Blood pressure increased
121177428 12117742 Chest discomfort
121177428 12117742 Chest pain
121177428 12117742 Dyspnoea
121177428 12117742 Fatigue
121177428 12117742 Heart rate increased
121177428 12117742 Hypercoagulation
121177428 12117742 Lower respiratory tract infection
121177428 12117742 Malaise
121177428 12117742 Myocardial infarction
121177428 12117742 Nasopharyngitis
121177428 12117742 Oxygen saturation decreased
121177428 12117742 Pain in extremity
121177428 12117742 Productive cough
121177428 12117742 Pruritus
121177428 12117742 Rash
121177428 12117742 Sputum discoloured
121177428 12117742 Thrombosis
121177428 12117742 Vomiting
121177428 12117742 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121177428 12117742 1 20081110 0
121177428 12117742 2 20151109 0
121177428 12117742 3 20151209 0
121177428 12117742 4 20151222 0
121177428 12117742 5 20160107 0
121177428 12117742 6 20160121 0
121177428 12117742 7 20160218 0
121177428 12117742 8 20160419 0
121177428 12117742 9 20160602 0
121177428 12117742 10 20160519 0
121177428 12117742 11 20160616 0
121177428 12117742 12 2009 0